| Wissenschaftl. Titel | An open label phase II study to evaluate the efficacy and safety of Inotuzumab Ozogamicin for Induction Therapy followed by a conventional chemotherapy based consolidation and maintenance therapy In patients aged 56 years and older with Acute Lymphoblastic leukemia (ALL) (INITIAL-1) |
| Erkrankung |
Haema:
ALL:
Erstlinie
|
| Kurzprotokoll | Kurzprotokoll |
| Links | Weiterführende Informationen (F) Weiterführende Informationen (NIH) Weiterführende Informationen (EudraCT) |
erstellt 19.11.2018 Data entry IX CCP
geändert 13.02.2024 Data entry III CCP